Rapamycin and Ageing: When, for How Long, and How Much?

Journal of Genetics and Genomics

Volumn 41, Issue 9, 2014, Pages 459-463

  Kaeberlein, Matt ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN;

AGING; ANIMAL EXPERIMENT; ARTICLE; FEMALE; INTERVENTION STUDY; LIFE EXTENSION; LIFESPAN; MALE; METABOLISM; MITOCHONDRION; NONHUMAN; ANIMAL; CLINICAL TRIAL (TOPIC); DOSE RESPONSE; DRUG EFFECTS; HUMAN; TIME FACTOR;

AGING; ANIMALS; CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MITOCHONDRIA; SIROLIMUS; TIME FACTORS;

EID: 84908897552     PISSN: 16738527     EISSN: 18735533     Source Type: Journal    
DOI: 10.1016/j.jgg.2014.06.009     Document Type: Article

References (37)

1. Anderson R.M., Weindruch R. The caloric restriction paradigm: implications for healthy human aging. Am. J. Hum. Biol. 2012, 24:101-106.
2. Anisimov V.N., Zabezhinski M.A., Popovich I.G., Piskunova T.S., Semenchenko A.V., Tyndyk M.L., Yurova M.N., Rosenfeld S.V., Blagosklonny M.V. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle 2011, 10:4230-4236.
3. Bjedov I., Toivonen J.M., Kerr F., Slack C., Jacobson J., Foley A., Partridge L. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab. 2010, 11:35-46.
4. Chen C., Liu Y., Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci. Signal. 2009, 2:ra75.
5. Ching T.T., Paal A.B., Mehta A., Zhong L., Hsu A.L. drr-2 encodes an eIF4H that acts downstream of TOR in diet-restriction-induced longevity of C. elegans. Aging Cell 2010, 9:545-557.
6. Fabrizio P., Pletcher S.D., Minois N., Vaupel J.W., Longo V.D. Chronological aging-independent replicative life span regulation by Msn2/Msn4 and Sod2 in Saccharomyces cerevisiae. FEBS Lett. 2004, 557:136-142.
7. Fabrizio P., Pozza F., Pletcher S.D., Gendron C.M., Longo V.D. Regulation of longevity and stress resistance by Sch9 in yeast. Science 2001, 292:288-290.
8. Flynn J.M., O'Leary M.N., Zambataro C.A., Academia E.C., Presley M.P., Garrett B.J., Zykovich A., Mooney S.D., Strong R., Rosen C.J., Kapahi P., Nelson M.D., Kennedy B.K., Melov S. Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell 2013, 12:851-862.
9. Harrison D.E., Strong R., Sharp Z.D., Nelson J.F., Astle C.M., Flurkey K., Nadon N.L., Wilkinson J.E., Frenkel K., Carter C.S., Pahor M., Javors M.A., Fernandez E., Miller R.A. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460:392-395.
10. Jia K., Chen D., Riddle D.L. The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 2004, 131:3897-3906.
11. Johnson S.C., Martin G.M., Rabinovitch P.S., Kaeberlein M. Preserving youth: does rapamycin deliver?. Sci. Transl. Med. 2013, 5:211-240.
12. Johnson S.C., Rabinovitch P.S., Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature 2013, 493:338-345.
13. Johnson S.C., Yanos M.E., Kayser E.B., Quintana A., Sangesland M., Castanza A., Uhde L., Hui J., Wall V.Z., Gagnidze A., Oh K., Wasko B.M., Ramos F.J., Palmiter R.D., Rabinovitch P.S., Morgan P.G., Sedensky M.M., Kaeberlein M. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science 2013, 342:1524-1528.
14. Kaeberlein M. Longevity and aging. F1000Prime Reports 2013, 5:5.
15. Kaeberlein M. mTOR inhibition: from aging to autism and beyond. Scientifica (Cairo) 2013, 2013:849186.
16. Kaeberlein M., Powers R.W., Steffen K.K., Westman E.A., Hu D., Dang N., Kerr E.O., Kirkland K.T., Fields S., Kennedy B.K. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 2005, 310:1193-1196.
17. Kapahi P., Chen D., Rogers A.N., Katewa S.D., Li P.W., Thomas E.L., Kockel L. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab. 2010, 11:453-465.
18. Kapahi P., Zid B. TOR pathway: linking nutrient sensing to life span. Science of aging knowledge environment: SAGE KE 2004, 2004:PE34.
19. Kapahi P., Zid B.M., Harper T., Koslover D., Sapin V., Benzer S. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr. Biol. 2004, 14:885-890.
20. Kennedy B.K., Steffen K.K., Kaeberlein M. Ruminations on dietary restriction and aging. Cell Mol. Life Sci. 2007, 64:1323-1328.
21. Lamming D.W., Ye L., Katajisto P., Goncalves M.D., Saitoh M., Stevens D.M., Davis J.G., Salmon A.B., Richardson A., Ahima R.S., Guertin D.A., Sabatini D.M., Baur J.A. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 2012, 335:1638-1643.
22. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
23. Masoro E.J. Overview of caloric restriction and ageing. Mech. Ageing Dev. 2005, 126:913-922.
24. Medvedik O., Lamming D.W., Kim K.D., Sinclair D.A. MSN2 and MSN4 link calorie restriction and TOR to sirtuin-mediated lifespan extension in Saccharomyces cerevisiae. PLoS Biol. 2007, 5:e261.
25. Miller R.A., Harrison D.E., Astle C.M., Baur J.A., Boyd A.R., de Cabo R., Fernandez E., Flurkey K., Javors M.A., Nelson J.F., Orihuela C.J., Pletcher S., Sharp Z.D., Sinclair D., Starnes J.W., Wilkinson J.E., Nadon N.L., Strong R. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66:191-201.
26. Miller R.A., Harrison D.E., Astle C.M., Fernandez E., Flurkey K., Han M., Javors M.A., Li X., Nadon N.L., Nelson J.F., Pletcher S., Salmon A.B., Sharp Z.D., Van Roekel S., Winkleman L., Strong R. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell 2014, 13:468-477.
27. Nadon N.L., Strong R., Miller R.A., Nelson J., Javors M., Sharp Z.D., Peralba J.M., Harrison D.E. Design of aging intervention studies: the NIA interventions testing program. Age (Dordr) 2008, 30:187-199.
28. Neff F., Flores-Dominguez D., Ryan D.P., Horsch M., Schroder S., Adler T., Afonso L.C., Aguilar-Pimentel J.A., Becker L., Garrett L., Hans W., Hettich M.M., Holtmeier R., Holter S.M., Moreth K., Prehn C., Puk O., Racz I., Rathkolb B., Rozman J., Naton B., Ordemann R., Adamski J., Beckers J., Bekeredjian R., Busch D.H., Ehninger G., Graw J., Hofler H., Klingenspor M., Klopstock T., Ollert M., Stypmann J., Wolf E., Wurst W., Zimmer A., Fuchs H., Gailus-Durner V., Hrabe de Angelis M., Ehninger D. Rapamycin extends murine lifespan but has limited effects on aging. J. Clin. Invest. 2013, 123:3272-3291.
29. Pan K.Z., Palter J.E., Rogers A.N., Olsen A., Chen D., Lithgow G.J., Kapahi P. Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans. Aging Cell 2007, 6:111-119.
30. Powers R.W., Kaeberlein M., Caldwell S.D., Kennedy B.K., Fields S. Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 2006, 20:174-184.
31. Robida-Stubbs S., Glover-Cutter K., Lamming D.W., Mizunuma M., Narasimhan S.D., Neumann-Haefelin E., Sabatini D.M., Blackwell T.K. TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metab. 2012, 15:713-724.
32. Selman C., Tullet J.M., Wieser D., Irvine E., Lingard S.J., Choudhury A.I., Claret M., Al-Qassab H., Carmignac D., Ramadani F., Woods A., Robinson I.C., Schuster E., Batterham R.L., Kozma S.C., Thomas G., Carling D., Okkenhaug K., Thornton J.M., Partridge L., Gems D., Withers D.J. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 2009, 326:140-144.
33. Steffen K.K., MacKay V.L., Kerr E.O., Tsuchiya M., Hu D., Fox L.A., Dang N., Johnston E.D., Oakes J.A., Tchao B.N., Pak D.N., Fields S., Kennedy B.K., Kaeberlein M. Yeast life span extension by depletion of 60s ribosomal subunits is mediated by Gcn4. Cell 2008, 133:292-302.
34. Vellai T., Takacs-Vellai K., Zhang Y., Kovacs A.L., Orosz L., Muller F. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 2003, 426:620.
35. Wilkinson J.E., Burmeister L., Brooks S.V., Chan C.C., Friedline S., Harrison D.E., Hejtmancik J.F., Nadon N., Strong R., Wood L.K., Woodward M.A., Miller R.A. Rapamycin slows aging in mice. Aging Cell 2012, 11:675-682.
36. Zhang Y., Bokov A., Gelfond J., Soto V., Ikeno Y., Hubbard G., Diaz V., Sloane L., Maslin K., Treaster S., Rendon S., van Remmen H., Ward W., Javors M., Richardson A., Austad S.N., Fischer K. Rapamycin extends life and health in C57BL/6 mice. J. Gerontol. A Biol. Sci. Med. Sci. 2014, 69:119-130.
37. Zid B.M., Rogers A.N., Katewa S.D., Vargas M.A., Kolipinski M.C., Lu T.A., Benzer S., Kapahi P. 4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila. Cell 2009, 139:149-160.